NCT04202237

Brief Summary

Kidney and Pancreas transplantation is considered the treatment of choice for many people with End Stage Renal Disease and Type 1 diabetes because quality of life and survival is often better after transplantation. However the quality of organs varies as does the quality of perfusion once they are transplanted. The immediate determinant of the survival of any transplanted allograft often depends on the overall quality of perfusion of the organ. The assessment of perfusion is currently visually and empirically done and reported by the surgical team, with low objectivity. The Laser Speckle Doppler technique will be used in both kidney and pancreas transplantation to objectively study the quality of blood flow to the kidney and pancreas after transplantation. This Doppler will provide continuous, non-invasive blood flow monitoring of the microvascular environment of the transplanted organ. The strength of the technique is in evaluating changes in flow over an area of interest or the whole transplanted organ and accurately numerically quantifying the flow. The laser speckle Doppler technique is now well established and has been used in various clinical and research setting as the most convenient means of assessing tissue blood flow. It has however not yet been used in kidney and pancreas transplantation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 6, 2019

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

December 11, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 17, 2019

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2021

Completed
Last Updated

October 5, 2021

Status Verified

October 1, 2021

Enrollment Period

1.6 years

First QC Date

December 11, 2019

Last Update Submit

October 4, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • To evaluate the use of the laser blood flow imager in both kidney and pancreas transplantation

    Doppler imaging of kidneys and pancreas

    3 months

Secondary Outcomes (1)

  • Measure the markers of inflammation ng/ml Hypo perfusion and oxidative stress (ng/ml) and attempt correlation with the quality of perfusion obtained

    6-12 months

Interventions

Speckle Doppler Laser imaging

Also known as: Laser Imaging

Blood sampling

Also known as: Venepuncture

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This study plans to recruit all recipients of, both kidney and pancreas transplants within a 14-week course of the study (Period of Lease of the Speckle Laser Doppler). It is expected that approximately n=60 kidney transplants (Living Donor, DBD and DCD and Marginal Kidneys) and n=8 pancreas transplant patients will be recruited in this study period. This will provide a range of grafts of varying quality of perfusion for assessment

You may qualify if:

  • Kidney Transplant Recipients
  • Age between 18 and 75 years
  • English Speaking as no funding for translators available
  • Able to provide written informed consent
  • Receiving a kidney transplant at Manchester University NHS Foundation Trust
  • Pancreas Transplant Recipients
  • Age between 18 and 75 years
  • English Speaking as no funding for translators available

You may not qualify if:

  • Outside of stated age range. Aged 76+

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Manchester University NHS Foundationn Trust

Manchester, Greater Manchester, M13 9WL, United Kingdom

Location

Related Publications (1)

  • Gopal JP, Vaz O, Varley R, Spiers H, Goldsworthy MA, Siddagangaiah V, Lock B, Sharma V, Summers A, Moinuddin Z, van Dellen D, Augustine T. Using Laser Speckle Contrast Imaging to Quantify Perfusion Quality in Kidney and Pancreas Grafts on Vascular Reperfusion: A Proof-of-Principle Study. Transplant Direct. 2023 Apr 19;9(5):e1472. doi: 10.1097/TXD.0000000000001472. eCollection 2023 May.

Biospecimen

Retention: SAMPLES WITH DNA

Plasma and cell pellets following blood centrifugation will be collected and stored.

MeSH Terms

Conditions

Rejection, Psychology

Interventions

Laser Speckle Contrast ImagingBlood Specimen Collection

Condition Hierarchy (Ancestors)

Social BehaviorBehavior

Intervention Hierarchy (Ancestors)

Optical ImagingDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisInvestigative TechniquesSpecimen HandlingClinical Laboratory TechniquesPuncturesSurgical Procedures, Operative

Study Officials

  • Titus Augustine, FRCS

    Manchester university foundation Trust

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 11, 2019

First Posted

December 17, 2019

Study Start

December 6, 2019

Primary Completion

July 30, 2021

Study Completion

July 30, 2021

Last Updated

October 5, 2021

Record last verified: 2021-10

Data Sharing

IPD Sharing
Will not share

Locations